From randomized trials to the clinic: Is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)

Annals of Oncology

Volumn 24, Issue 3, 2013, Pages 586-597

  Couraud, S ^a,b   Cortot, A B ^c   Greillier, L ^d   Gounant, V ^e   Mennecier, B ^f   Girard, N ^a,b   Besse, B ^g   Brouchet, L ^h   Castelnau, O ⁱ   Frappe P ^j   Ferretti, G R ^k   Guittet, L ^l   Khalil, A ^m   Lefebure, P ⁿ   Laurent, F ^o   Liebart, S ^j   Molinier, O ^p   Quoix, E ^f   Revel, M P ^q   Stach, B ⁿ   Souquet, P J ^a,b   Thomas, P ^r   Tredanie J ^s   Lemarie E ^t   Zalcman, G ^l   Barles F ^d   Milleron, B ^e,u   more..

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁱ INSTITUT ARNAULT TZANCK   (France)

^j UNIVERSITÉ JEAN MONNET   (France)

^k GRENOBLE UNIVERSITY HOSPITAL   (France)

^l CAEN UNIVERSITY HOSPITAL   (France)

^m HÔPITAL TENON   (France)

ⁿ General Practician   (France)

^o BORDEAUX UNIVERSITY HOSPITAL   (France)

^p General Hospital of le Mans   (France)

^q ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^r AIX MARSEILLE UNIVERSITÉ   (France)

^s UNIVERSITÉ PARIS DESCARTES   (France)

^t UNIVERSITÉ DE TOURS   (France)

^u Intergroupe Francophone de Cancérologie Thoracique IFCT   (France)

more..

Author keywords

Low dose CT scan; Lung cancer; Lung nodule; Screening; Tobacco.

Indexed keywords

AGE; ALGORITHM; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER THERAPY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER; FRANCE; HUMAN; LUNG CANCER; MEDICAL EXPERT; MEDICAL SOCIETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SMOKING; SMOKING CESSATION; THORAX RADIOGRAPHY; WORKSHOP;

EID: 84874565788     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds476     Document Type: Review

References (69)

1. Henschke CI, Yankelevitz DF, Libby DM et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355(17): 1763-1771.
2. Raz DJ, Zell JA, Ou S-HI et al. Natural History of Stage I Non-Small Cell Lung Cancer: Implications for Early Detection. Chest 2007; 132(1): 193-199.
3. Nawa T, Nakagawa T, Mizoue T et al. Long-term prognosis of patients with lung cancer detected on low-dose chest computed tomography screening. Lung Cancer 2012; 75(2): 197-202.
4. Frost JK, Ball WC, Jr, Levin ML et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984; 130(4): 549-554.
5. Marcus PM, Bergstralh EJ, Fagerstrom RM et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000; 92 (16): 1308-1316.
6. Oken MM, Hocking WG, Kvale PA et al. Screening by Chest Radiograph and Lung Cancer Mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial. JAMA: The Journal of the American Medical Association 2011; 306(17): 1865-1873.
7. The National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Eng J Med 2011; 365(5): 395-409.
8. National Lung Screening Trial Research Team. The National Lung Screening Trial: Overview and Study Design. Radiology 2010; 258(1): 243-253.
9. Infante M, Cavuto S, Lutman FR et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009; 180(5): 445-453.
10. Blanchon T, Bréchot J-M, Grenier PA et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007; 58(1): 50-58.
11. Hocking WG, Hu P, Oken MM et al. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst 2010; 102(10): 722-731.
12. Veronesi G, Bellomi M, Mulshine JL et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008; 61(3): 340-349.
13. Veronesi G, Bellomi M, Scanagatta P et al. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. The Journal of Thoracic and Cardiovascular Surgery 2008; 136(3): 611-617.
14. Veronesi Giulia. Diagnostic Performance of annual LD-CT screenign for lung cancer after five years, MO05.02 [Internet]. Amsterdam; 2011 [cited 2012 Jul 24]. https://www.webges.com/cslide/library/wclc/.com.
15. van Klaveren RJ, Oudkerk M, Prokop M et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361(23): 2221-2229.
16. Pedersen JH, Ashraf H, Dirksen A et al. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J Thorac Oncol 2009; 4(5): 608-614.
17. Lopes Pegna A, Picozzi G, Mascalchi M et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009; 64(1): 34-40.
18. Baldwin DR, Duffy SW, Wald NJ et al. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 2011; 66(4): 308-313.
19. van Iersel CA, de Koning HJ, Draisma G et al. Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007; 120(4): 868-874.
20. Paci E. Abstract SS03-03: The ITALUNG study and the state of art of randomized screening trials in Europe. Cancer Prevention Research 2011; 4(Suppl 10): http://cancerpreventionresearch.aacrjournals.org/content/by/year/2011.
21. Henschke CI, Boffetta P, Gorlova O et al. Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer 2011; 71(3): 328-332.
22. Veronesi Gulia. Long-Term outcomes of a pilot CT screening for lung cancer: 10years results, MO05.07 [Internet]. Amsterdam; 2011 [cited 2012 Jul 23]. https://www.webges.com/cslide/library/wclc/.com.
23. Veronesi G, Maisonneuve P, Spaggiari1 L et al. Long-term outcomes of a pilot CT screening for lung cancer. Ecancermedicalscience 2010; 4: 186.
24. France, ANAES. Guide Méthodologique: Comment Évaluer A Priori Un Programme De Dépistage? [Internet]. Saint denis La Plaine: Agence Nationale d'Accréditation et d'Evaluation en Santé; 2004 Mai. Available from: http://www. has-sante.fr/portail/jcms/c_433375/comment-evaluer-a-priori-un-programmede-depistage?xtmc=depistage&xtcr=1.
25. Pastorino U, Rossi M, Rosato V et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012; 21(3): 308-315.
26. Maisonneuve P, Bagnardi V, Bellomi M et al. Lung cancer risk prediction to select smokers for screening CT-a model based on the Italian COSMOS trial. Cancer Prev Res (Phila) 2011; 4(11): 1778-1789.
27. Henschke CI, Yankelevitz DF, McCauley DI et al. Guidelines for the use of spiral computed tomography in screening for lung cancer. Eur Respir J Suppl 2003; 39: 45s-51s.
28. Field JK, Smith RA, Aberle DR et al. International association for the study of lung cancer computed tomography screening workshop 2011 report. J Thorac Oncol 2012; 7(1): 10-19.
29. Kim MJ, Park CH, Choi SJ et al. Multidetector computed tomography chest examinations with low-kilovoltage protocols in adults: effect on image quality and radiation dose. J Comput Assist Tomogr 2009; 33(3): 416-421.
30. Manowitz A, Sedlar M, Griffon M et al. Use of BMI guidelines and individual dose tracking to minimize radiation exposure from low-dose helical chest CT scanning in a lung cancer screening program. Acad Radiol 2012; 19(1): 84-88.
31. Jankowski A, Martinelli T, Timsit JF et al. Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection. Eur Radiol 2007; 17(12): 3148-3156.
32. Wormanns D, Ludwig K, Beyer F et al. Detection of pulmonary nodules at multirow-detector CT: effectiveness of double reading to improve sensitivity at standard-dose and low-dose chest CT. Eur Radiol 2005; 15(1): 14-22.
33. Wang Y, van Klaveren RJ, de Bock GH et al. No benefit for consensus double reading at baseline screening for lung cancer with the use of semiautomated volumetry software. Radiology 2012; 262(1): 320-326.
34. France, IRSN. Bilan de l'état radiologique de l'environnement français en 2009 Synthése des résultats des réseaux de surveillance de l'IRSN [Internet]. Paris: Institut de Radioprotection et de Sureté Nucléaire (IRSN); 2011. http://www.irsn. fr/FR/expertise/rapports_expertise/Documents/environnement/ IRSN_surveillance_France_2009.pdf.
35. France, IRSN. Doses délivrées aux patients en scanographie et en radiologie conventionnelle Résultats d'une enquête multicentrique en secteur public [Internet]. Paris: Institut de Radioprotection et de Sureté Nucléaire (IRSN); 2010. Report No.: DRPH/SER No 2010-12. http://www.irsn.fr/FR/expertise/rapports_ expertise/Documents/radioprotection/IRSN-Rapport-dosimetrie-patient-2010-12.pdf.
36. Kong CY, Lee JM, McMahon PM et al. Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections. Radiology 2012; 262(3): 977-984.
37. Mascalchi M, Mazzoni LN, Falchini M et al. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT. Br J Radiol 2012; 85(1016): 1134-1139.
38. Zerhouni EA, Stitik FP, Siegelman SS et al. CT of the pulmonary nodule: a cooperative study. Radiology 1986; 160(2): 319-327.
39. Ahn MI, Gleeson TG, Chan IH et al. Perifissural Nodules Seen at CT Screening for Lung Cancer. Radiology 2010; 254(3): 949-956.
40. Xu DM, Gietema H, de Koning H et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006; 54(2): 177-184.
41. Godoy MCB, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009; 253(3): 606-622.
42. Takashima S, Sone S, Li F et al. Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR Am J Roentgenol 2003; 180(5): 1255-1263.
43. France, INCa. © Cancer du poumon, Bilan initial. [Internet]. Boulogne Billancourt: INCa-Institut National du Cancer; juin 20101 p. 46. http://www.ecancer. fr/soins/recommandations/cancers-bronchopulmonaires-et-pleuraux.
44. van't Westeinde SC, de Koning HJ, Thunnissen FB et al. The role of the 18ffluorodeoxyglucosepositron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial. J Thorac Oncol 2011; 6(10): 1704-1712.
45. van 't Westeinde SC, Horeweg N, Vernhout RM et al. The role of conventional bronchoscopy in the work-up of suspicious CT screen detected pulmonary nodules. Chest 2012 Feb 2 [cited 2012 Mar 9]; [Epub ahead of print].
46. Travis WD, Brambilla E, Noguchi M et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011; 6(2): 244-285.
47. Rami-Porta R, Tsuboi M. Sublobar resection for lung cancer. Eur Respir J 2009; 33(2): 426-435.
48. France, SFCTCV, France, INCA. Cancer primitif non á petites cellules du poumon?: pratiques chirurgicales. Recommandations; Rapport intégral. [Internet]. Société Franáaise de Chirurgie Thoracique et Cardio-Vasculaire et Institut National du Cancer; http://www.e-cancer.fr/soins/recommandations/cancersbronchopulmonaireset-pleuraux.
49. Becker N, Delorme S, Kauczor H. LUSI: the german component of the european trial on the efficacy of multisclice-CT for the early detection of lung cancer. Onkologie 2008; 31(suppl 1): 130.
50. Saghir Z, Dirksen A, Ashraf H et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012; 67(4): 296-301.
51. Stefanek ME. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening. J Natl Cancer Inst 2011; 103(24): 1821-1826.
52. Wegwarth O, Schwartz LM, Woloshin S et al. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med 2012; 156(5): 340-349.
53. Wood DE, Eapen GA, Ettinger DS et al. Lung cancer screening. J Natl Compr Canc Netw 2012; 10(2): 240-265.
54. Italian lung cancer CT screening trial workshop. International workshop on randomized lung cancer screening trials. State of the art in Europe after early conclusion of the US National Lung Screening Trial [Internet]. Osservatorio Nazionale Screening Official Website. 2011 [cited 2012 Jul 27]. Available from: http://www.studio-sesto.com/ons/images/stories/ pisa_position_statement_english.pdf.
55. Bach PB, Mirkin JN, Oliver TK et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012; 307(22): 2418-2429.
56. Bellizzi KM, Breslau ES, Burness A et al. Prevalence of cancer screening in older, racially diverse adults: still screening after all these years. Arch Intern Med 2011; 171(22): 2031-2037.
57. Morére J-F, Pivot X, Viguier J et al. Breast cancer screening in women aged 5074 years: is there room for improvement? Eur J Cancer Prev 2011; 20(Suppl 1): S8-S12.
58. Pornet C, Dejardin O, Morlais F et al. Socioeconomic and healthcare supply statistical determinants of compliance to mammography screening programs: a multilevel analysis in Calvados, France. Cancer Epidemiol 2010; 34(3):
59. Aberle DR, Adams AM, Berg CD et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010; 102(23): 1771-1779.
60. Booth CM, Li G, Zhang-Salomons J et al. The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer 2010; 116(17): 4160-4167.
61. Cassidy A, Myles JP, van Tongeren M et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008; 98(2): 270-276.
62. McMahon PM, Kong CY, Bouzan C et al Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011; 6(11): 1841-1848.
63. Ferketich AK, Otterson GA, King M et al. A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung Cancer 2012; 76(2): 211-215.
64. van der Aalst CM, van Klaveren RJ, van den Bergh KAM et al. The impact of a lung cancer computed tomography screening result on smoking abstinence. Euro Respir J 2010; 37(6): 1466-1473.
65. Dinnes J, Moss S, Melia J et al. Effectiveness and cost-effectiveness of double reading of mammograms in breast cancer screening: findings of a systematic review. Breast 2001; 10(6): 455-463.
66. Ciatto S, Ambrogetti D, Bonardi R et al. Second reading of screening mammograms increases cancer detection and recall rates. Results in the Florence screening programme. J Med Screen 2005; 12(2): 103-106.
67. Gierada DS, Garg K, Nath H et al. CT quality assurance in the Lung Screening Study Component of the National Lung Screening Trial: implications for multicenter imaging trials. Am J Roentgenol 2009; 193(2): 419-424.
68. Boeri M, Verri C, Conte D et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011; 108(9): 3713-3718.
69. Bianchi F, Nicassio F, Marzi M et al A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 2011; 3(8): 495-503.